Mbm 13 Female
FDA Label NDC 57520-0216

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Apotheca Company for the product Mbm 13 Female (NDC 57520-0216). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, warnings, dosage & administration, inactive ingredient, otc - questions, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

ACTIVE INGREDIENTS:  Phytolacca decandra 3C, Pituitarinum gland 3C, Scrophularia nodosa 3C, Hypothalamus gland 5C, Calcarea carbonica 89C, Cimicifuga racemosa 89C, Lilium tigrinum 89C, Sulphur 89C, Causticum 144C, Graphites 144C, Kali phosphoricum 233C.

Otc - Purpose

INDICATIONS:  For temporary relief of emotionlessness, denial, numbness, and unresponsiveness.

Warnings

WARNINGS:  If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.  In case of overdose, get medical help or contact a Poison Control Center right away.  Do not use if seal is broken or missing.

Dosage & Administration

DIRECTIONS:  Feel the emotion fully, breathe deeply-connected breaths.  Put 5 drops under tongue to release emotion.  Continue 5 drops 2 times daily as needed.  Consult a physician for use in children under 12 years of age.

Inactive Ingredient

INACTIVE INGREDIENTS:  Demineralized water, 25% Ethanol


Otc - Questions


MFD. FOR:

Theresa Dale, N.D.

1237 S. Victoria Ave.

Oxnard, CA 93035


Package Label.Principal Display Panel

Dr. Theresa Dale's

MIND-BODY-MERIDIAN

Fibonacci Series

13

Female

Unresponsive

HOMEOPATHIC

1 fluid oz. (30 ml)

Mbm 13 Female (Mm1)

Mbm 13 Female (Mm1)

* Please review the disclaimer below.